Jul. 1, 2024: Our work entitled "A Semisynthetic Oligomannuronic Acid-Based Glycoconjugate Vaccine against Pseudomonas aeruginosa" has been accepted by ACS Central Science. Congratulations to Yiyue and Xiaotong!